Please login to the form below

Not currently logged in
Email:
Password:

Sudler & Hennessey - Johannesburg office

Sudler & Hennessey has expanded its global presence with the addition of the Sherwood Sudler & Hennessey office in Johannesburg

Sudler & Hennessey has expanded its global presence with the addition of the Sherwood Sudler & Hennessey office in Johannesburg, South Africa.

Sudler & Hennessey has partnered with Martin Sherwood, a long-term healthcare industry veteran, to establish a new, innovative healthcare agency in Johannesburg. Sherwood Sudler & Hennessey will serve as a hub to deliver advertising and promotional needs for pharmaceutical and healthcare agencies in the greater South Africa region. 

Martin Sherwood's expertise brings a full complement of market development services including creative execution, and innovative thinking, plus a specialised focus on high-level strategy.

Max Jackson, president of S&H EMEA said: "We are delighted Martin Sherwood has joined the S&H network. The Johannesburg market is an attractive one, as there is a lack of healthcare agencies in the area and this office will allow pharmaceutical and healthcare companies to finally deliver a high level of strategy to both the professional and consumer audiences.

"Together with the global excellence of S&H, we will now be able to provide healthcare solutions to the South Africa region that, up to this point, has been lacking."

9th December 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a team outstanding healthcare communications experts who provide innovative strategic evidence based solutions through scientific and commercial...

Latest intelligence

Growing influence of pharmacists in the sale of Rx and OTC medicines
Find out how the changes within pharmacy have affected their influence over the sales of RX and OTC medicines in this whitepaper....
Drivers of 2014′s Soaring Drug Approvals
The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...
Russian innovation at the crossroads
Despite improvements, investors face rising risks...